October 12, 2015
October 12, 2015 —
Many leukemias are caused by loss of the enzyme Pten. Some anti-leukemia treatments work by inhibiting another enzyme called Shp2. Researchers at University of California, San Diego School of Medicine have now found that mice lacking both of these enzymes can’t produce and sustain enough red blood cells. The study, published October 12 by PNAS, helps explain why anemia is a common side effect of anti-cancer drugs that target enzymes involved in tumor growth.
October 7, 2015
October 7, 2015 —
University of California, San Diego School of Medicine’s Rob Knight, PhD, and his team built a microbiome analysis platform called QIIME (pronounced “chime” and short for “Quantitative Insights Into Microbial Ecology”). This software will now be more readily accessible to hundreds of thousands of researchers around the world through BaseSpace, a cloud-based app store offered by Illumina, a San Diego-based company that develops life science tools for the analysis of genetic variation.
October 5, 2015
October 5, 2015 —
Under its new 4D Nucleome Program, the National Institutes of Health (NIH) Common Fund has awarded three grants totaling more than $30 million over five years to multidisciplinary teams of researchers at University of California, San Diego.
October 2, 2015
October 2, 2015 —
First introduced in the United States in 2007, electronic cigarettes have risen dramatically in part because they are popularly considered safer and more socially acceptable than combustible cigarettes and because there are fewer restrictions on their purchase and use. A study by University of California, San Diego School of Medicine researchers, published in the journal Drug and Alcohol Dependence, points to aggressive online marketing tactics that make purchasing e-cigarettes easy for all ages.
October 1, 2015
October 1, 2015 —
Researchers at the University of California, San Diego School of Medicine say that hepatic fibrosis, which involves scarring of the liver that can result in dysfunction and, in severe cases, cirrhosis and cancer, may be as much a consequence of genetics as environmental factors.
September 30, 2015
September 30, 2015 —
UC San Diego Health has been designated a member of the National Network of Depression Centers (NNDC), a consortium of leading academic medical centers working to accelerate research, education and improved treatment options for people with depressive and bipolar illnesses. UC San Diego Health joins 22 other institutions in the nationwide nonprofit network.
September 29, 2015
September 29, 2015 —
The votes are in and more than 100 physicians from UC San Diego Health were named “Top Docs” in the annual San Diego Magazine “Physicians of Exceptional Excellence” annual survey. These physicians represent 41 diverse specialties, from family medicine, surgery and oncology to obstetrics, cardiology and emergency medicine.
September 28, 2015
September 28, 2015 —
A collaborative program aimed at reducing the burden of cancer among Hispanic/Latinos in San Diego and Imperial counties through research and community outreach has received a $13 million grant from the National Cancer Institute (NCI), part of the National Institutes of Health. The five-year grant renews funding for a partnership started in 2008 between San Diego State University and Moores Cancer Center at UC San Diego Health.
September 25, 2015
September 25, 2015 —
The third annual Breakfast with Champions is scheduled for Wednesday, September 30 from 8:00 to 10:00 a.m. at the La Jolla Country Club. The event, which is open to the public, features a presentation by nine-time Pro Bowl safety and analyst for the NFL on FOX, John Lynch. All proceeds will benefit prostate cancer research at Moores Cancer Center at UC San Diego Health.
September 22, 2015
September 22, 2015 —
The National Institutes of Health has awarded a $13 million grant over five years to develop and disseminate new stem cell-based technologies and assays for studying autism spectrum disorder (ASD) and other mental health diseases to a consortium of researchers at the University of California, San Diego and the Salk Institute for Biological Studies, working in tandem with leaders in the biotechnology sector.
